Research
Hormonal
Results marginally favored the use of AEL, but did not support significant improvements in body composition or hormonal responses.
AEL may have slight advantages, but practitioners should not expect major changes in outcomes.
StrongQualifiesmedium confidence
Whilst the results marginally favored the use of AEL, these results did not support significant improvements in body composition or hormonal responses.
Why this rating
Based on study design from abstract.
Source
The Endocrine and Body Composition Responses to Accentuated Eccentric Loading Performed in Cluster Sets During a Strength–Endurance Training Block
Kurt W. McDowell et al. · Applied Sciences · 2024
DOI 10.3390/app142311332
other · n=17Cited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →